Investing in Women’s Health: The $12 Billion Allocation and Its Impact on Global Healthcare Priorities

The $12 billion allocated for women’s health research is considered one of the most significant moves made by an administration in this field. This investment has not only impacted the global community, leading to other countries and states also investing in women’s health, but has also raised concerns in the United States.

While the U.S. continues to navigate the intersection of politics and science, the global healthcare sector is already reshaping its language and prioritizing investments in women’s health research. The podcast episode hosted by Lori Ellis, Head of Insights at BioSpace, features esteemed guests including Sans Thakur, Founder and Chairwoman of Tower Capital; Chia Chia Sun, Chief Commercial Officer at Fab Biopharma; Elisa Cascade, Chief Product Officer at Advarra; Shawana Moore, Medical Advisor on the Advisory Council for Healthy Women; and Katie Schubert, President and Chief Executive Officer of the Society for Women’s Health.

The funding in the U.S. is not certain and relies on congressional approval, which can be complicated, especially during an election year. However, this podcast episode can be listened to on various platforms including Spotify, Apple Podcasts, Amazon Music, and iHeart.